Register entry

Orphalan SA

Data as of · How to read this entry

Registered sites
0
Active NDC listings
1
Live patents
5
Exclusivities
1
Countries
0
Exclusivity

Patents and exclusivities

5
PatentProductCoversExpiry
10988436CUVRIORtrientine tetrahydrochloridesubstanceMay 2039
11072577CUVRIORtrientine tetrahydrochlorideuseMay 2039
12358861CUVRIORtrientine tetrahydrochloridesubstance, productMay 2039
12358862CUVRIORtrientine tetrahydrochloridesubstance, productMay 2039
12662445CUVRIORtrientine tetrahydrochloridesubstance, productMay 2039
ProductExclusivityUntil
CUVRIORTRIENTINE TETRAHYDROCHLORIDEODE-401 Orphan drugApr 2029
Catalogue

Marketed products

1
BrandGeneric nameForm / routeNDC
CUVRIORTRIENTINE TETRAHYDROCHLORIDEtablet, film coated, oral81802-001NDA
Enquiry

Common questions

Is Orphalan SA FDA approved?
Orphalan SA holds no registered establishment of its own; 1 drug product is listed under its name in the National Drug Code Directory, made at sites registered to other firms.
What drugs does Orphalan SA make?
1 product is listed under Orphalan SA in the openFDA NDC Directory, most often as tablet, film coated. The full breakdown by dosage form and route is above. A listing count is not a sales figure.

Compiled from FDA establishment registrations, the openFDA NDC Directory, the Orange Book and the FDA drug shortage database. Not claimed by the company. Sources and methodology.